{"id":"W4282966850","doi":"10.1093/eurjpc/zwac107","title":"Achievement of ESC/EAS LDL-C treatment goals after an acute coronary syndrome with statin and alirocumab","year":2022,"lang":"en","type":"article","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; University of Alberta; St. Michael's Hospital","funders":"American Regent; Regeneron Pharmaceuticals; National Institutes of Health; GlaxoSmithKline; HLS Therapeutics; Servier; Duke Clinical Research Institute; Astellas Pharma; Novo Nordisk; Daiichi-Sankyo; St. Jude Medical; Boston Scientific Corporation; Pfizer; York University; Cleveland Clinic; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; CSL Behring; University of Toronto; Heart and Stroke Foundation of Canada; European Commission; Sanofi; Esperion Therapeutics; Amgen","keywords":"Alirocumab; Medicine; Ezetimibe; Acute coronary syndrome; Interquartile range; Statin; Internal medicine; Placebo; Cardiology; Cholesterol; Lipoprotein; Myocardial infarction","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001610384,0.0001858796,0.0008658653,0.0001365158,0.00008531554,0.000005884307,0.0001078716,0.00001818353,0.00009721439],"category_scores_gemma":[0.0000119834,0.0001299176,0.0003284382,0.00009245659,0.0001254802,0.00007680729,0.0001188207,0.0002545799,0.000002084467],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001512236,"about_ca_system_score_gemma":0.0001673352,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001150448,"about_ca_topic_score_gemma":0.000001349551,"domain_scores_codex":[0.996308,0.002314911,0.0005155799,0.0002401155,0.0003921159,0.0002293231],"domain_scores_gemma":[0.9988996,0.00002750046,0.0003801153,0.0003306158,0.0001568493,0.0002053328],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03233137,0.002932589,0.3346706,0.0005896365,0.05042354,0.2606797,0.00999222,0.001338417,0.007322602,0.0002020574,0.0008920032,0.2986253],"study_design_scores_gemma":[0.007160844,0.0414862,0.8993113,0.0001070455,0.001755252,0.04193827,0.001159765,0.000002815356,0.0002019729,0.00002885792,0.006682421,0.0001652695],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941468,0.003182962,0.0014186,0.0001794536,0.0001264065,0.0004738323,0.00009130764,0.000007153549,0.0003734853],"genre_scores_gemma":[0.997512,0.0005907139,0.001255627,0.0001577263,0.0001188774,0.00002056833,0.00002507823,0.00003844863,0.0002808964],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5646406,"threshold_uncertainty_score":0.5297887,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01192085290350001,"score_gpt":0.253230899390221,"score_spread":0.241310046486721,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}